Purpose Patient participation in cancer clinical trials is imperative to the advancement of
medical science. Physicians play an important role in recruitment by discussing clinical trials …

Background/Aims Essential to bringing innovative cancer treatments to patients is voluntary
participation in clinical trials but approximately 8% of American cancer patients are enrolled …

Background Clinical trials are vital for evidence-based cancer care. Oncologist engagement
in clinical trials has an effect on patient recruitment, which in turn can affect trial success …

Background Clinical trials are critical for evaluating new cancer therapies, but few adult
patients participate in them. Physicians have an important role in facilitating patient …

Background Provider and institutional practices have been shown to have a large impact on
cancer clinical trial enrollment. Understanding provider perspectives on screening for trial …

Fewer than 1 in 20 adult cancer patients enroll in cancer clinical trials. But although barriers
to trial participation have been the subject of frequent study, the rate of trial participation has …

Abstract Purpose The Tufts Center for the Study of Drug Development conducted a study
among practicing physicians and nurses (health care providers) across multiple specialties …

Purpose: Less than 5% of patients with cancer participate in trials. Few studies have
specifically addressed the role of cost to the patient as an influence on trial participation. Our …

Background Barriers to cancer clinical trial participation have been the subject of frequent
study, but the rate of trial participation has not changed substantially over time. Studies often …

Introduction Prospective clinical trials are essential to translate new therapy concepts or
rather any scientific development into the medical routine. Besides a sophisticated trial …